Clinical Trial Update: Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation, randomized trial assessing safety, immunogenicity and efficacy of the PfSPZ Vaccine in Tanzanian adults; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Plasmodium Falciparum Malaria

Drugs mentioned

• PfSPZ Vaccine (Plasmodium falciparum sporozoite vaccine)

Snippet

Sponsor: Sanaria Inc. | Conditions: Malaria, Plasmodium Falciparum Malaria | Phase 1 | Status: COMPLETED